We have developed a suitable radiolabeling method for our new type of
glycoprotein-
liposome conjugate (GCL), in order to investigate its potential utility as a
drug carrier that can target the cellular functions of
carbohydrate-
binding proteins. In order to obtain radiolabeled GCL with high labeling efficiency, we introduced p-hydroxyphenylpropyl groups into the
liposome membrane through the
amine moiety of a constitutive
phospholipid, dipalmitoylphosphatidylethanolamine (
DPPE) by using
Bolton-Hunter reagent (BHR). Radioiodination of the introduced tyrosyl groups was performed by the
Chloramine-T method. The labeling efficiency of the BHR-treated
liposome conjugate was high in comparison with that of the BHR-untreated
liposome conjugate. An in vitro inhibition study showed that the binding affinity of 125I-labeled BHR-treated GCL (125I-F3S-BH) with
lectin was twice as high as that of untreated conjugate (125I-F3S). The biodistribution of 125I-F3S-BH in mice was considerably different from that of 125I-F3S. 125I-F3S-BH was more rapidly taken up by the liver and was more rapidly excreted from the liver than 125I-F3S. Moreover, 125I-F3S-BH accumulated more rapidly into the kidneys, which resulted a lower radioactivity in the blood circulation at an earlier time point than in the case of 125I-F3S. The characteristics of
tumor accumulation of 125I-F3S-BH and 125I-F3S were similar to those in blood. If F3S is to be employed as an in vivo targeting
ligand in biodistribution studies, BHR would be a suitable tool for radiolabeling because it allows GCL to retain the
biological activity and characteristics of the unmodified conjugate.